Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DTST | Common Stock | Options Exercise | +2.5K | +14.29% | 20K | Mar 31, 2024 | Direct | F1, F2 | ||
transaction | DTST | Common Stock | Award | $0 | +2.5K | +12.5% | $0.00 | 22.5K | Mar 31, 2024 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DTST | Restricted Stock Unit | Options Exercise | $0 | -2.5K | -100% | $0.00* | 0 | Mar 31, 2024 | Common Stock | 2.5K | Direct | F1, F2, F4 | |
transaction | DTST | Option to Purchase Stock | Award | $0 | +2.5K | $0.00 | 2.5K | Mar 31, 2024 | Common Stock | 2.5K | $5.72 | Direct | F5 |
Id | Content |
---|---|
F1 | Restricted stock units ("RSUs") convert into common stock on a one-for-one basis and represent a contingent right to receive one share of the Issuer's common stock. |
F2 | On March 31, 2023 the reporting person was granted 2,500 RSUs, which vested on March 31, 2024. The total amount of securities beneficially owned after this issuance reflects a correction from the Form 4 filed by Mr. Grover on January 3, 2024, which should have disclosed 17,500 shares beneficially owned at that time rather than 17,250. |
F3 | Represents the shares of the Issuer's common stock underlying an RSU grant to Mr. Grover on March 31, 2024, which RSUs vest on the one-year anniversary of the date of grant. |
F4 | The amount of derivative securities beneficially owned by Mr. Grover following the reported transaction is correctly reported on this Form 4. The amount of derivative securities beneficially owned by Mr. Grover following the reported transaction has been adjusted to correct errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on July 5, 2023, October 11, 2023, January 3, 2024 and April 2, 2024, each of which indicated the balance of derivative securities beneficially owned by Mr. Grover following the reported transaction as being 2,500 greater than the actual number that should have been reported. |
F5 | These options ("Options") vest and become exercisable in three equal annual installments over the three-year period measured from March 31, 2024, vesting commencing on March 31, 2025. These Options will expire on March 30, 2034. |